132 related articles for article (PubMed ID: 33001012)
41. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
[TBL] [Abstract][Full Text] [Related]
42. The Cannabinoid Delta-9-tetrahydrocannabinol Disrupts Estrogen Signaling in Human Placenta.
Maia J; Almada M; Midão L; Fonseca BM; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
Toxicol Sci; 2020 Oct; 177(2):420-430. PubMed ID: 32647869
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
DeLong GT; Wolf CE; Poklis A; Lichtman AH
Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971
[TBL] [Abstract][Full Text] [Related]
44. Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells.
Takeda S; Ikeda E; Su S; Harada M; Okazaki H; Yoshioka Y; Nishimura H; Ishii H; Kakizoe K; Taniguchi A; Tokuyasu M; Himeno T; Watanabe K; Omiecinski CJ; Aramaki H
Toxicology; 2014 Dec; 326():18-24. PubMed ID: 25291031
[TBL] [Abstract][Full Text] [Related]
45. Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.
Karmaus PW; Chen W; Crawford R; Kaplan BL; Kaminski NE
Toxicol Sci; 2013 Feb; 131(2):419-33. PubMed ID: 23152191
[TBL] [Abstract][Full Text] [Related]
46. Δ
Takeda S; Hirao-Suzuki M; Aramaki H; Watanabe K
Forensic Toxicol; 2023 Jul; 41(2):287-293. PubMed ID: 36583834
[TBL] [Abstract][Full Text] [Related]
47. Marihuana-like activity of new synthetic tetrahydrocannabinols.
Martin BR; Dewey WL; Harris LS; Beckner J
Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
[TBL] [Abstract][Full Text] [Related]
48. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
Verhoeckx KC; Korthout HA; van Meeteren-Kreikamp AP; Ehlert KA; Wang M; van der Greef J; Rodenburg RJ; Witkamp RF
Int Immunopharmacol; 2006 Apr; 6(4):656-65. PubMed ID: 16504929
[TBL] [Abstract][Full Text] [Related]
49. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
[TBL] [Abstract][Full Text] [Related]
50. Different responses of repetitive behaviours in juvenile and young adult mice to Δ
Gorberg V; McCaffery P; Anavi-Goffer S
Br J Pharmacol; 2021 Feb; 178(3):614-625. PubMed ID: 33125731
[TBL] [Abstract][Full Text] [Related]
51. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase.
Bayewitch M; Rhee MH; Avidor-Reiss T; Breuer A; Mechoulam R; Vogel Z
J Biol Chem; 1996 Apr; 271(17):9902-5. PubMed ID: 8626625
[TBL] [Abstract][Full Text] [Related]
52. Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.
Balster RL; Prescott WR
Neurosci Biobehav Rev; 1992; 16(1):55-62. PubMed ID: 1313164
[TBL] [Abstract][Full Text] [Related]
53. Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC).
Mayer TA; Matar MA; Kaplan Z; Zohar J; Cohen H
Pharmacol Biochem Behav; 2014 Jul; 122():307-18. PubMed ID: 24814135
[TBL] [Abstract][Full Text] [Related]
54. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
55. Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.
Hernán Pérez de la Ossa D; Lorente M; Gil-Alegre ME; Torres S; García-Taboada E; Aberturas Mdel R; Molpeceres J; Velasco G; Torres-Suárez AI
PLoS One; 2013; 8(1):e54795. PubMed ID: 23349970
[TBL] [Abstract][Full Text] [Related]
56. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action.
Salazar M; Lorente M; García-Taboada E; Hernández-Tiedra S; Davila D; Francis SE; Guzmán M; Kiss-Toth E; Velasco G
Biochim Biophys Acta; 2013 Oct; 1831(10):1573-8. PubMed ID: 23567453
[TBL] [Abstract][Full Text] [Related]
57. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
58. In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.
Marshell R; Kearney-Ramos T; Brents LK; Hyatt WS; Tai S; Prather PL; Fantegrossi WE
Pharmacol Biochem Behav; 2014 Sep; 124():40-7. PubMed ID: 24857780
[TBL] [Abstract][Full Text] [Related]
59. Animal evidence considered in determination of cannabis smoke and Δ
Campbell MA; Iyer P; Kaufman F; Kim A; Moran F; Niknam Y; Wu L; Sandy MS; Zeise L
Birth Defects Res; 2022 Nov; 114(18):1143-1154. PubMed ID: 36177831
[TBL] [Abstract][Full Text] [Related]
60. Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ⁹-THC.
Coskun ZM; Bolkent S
Cell Biochem Funct; 2014 Oct; 32(7):612-9. PubMed ID: 25187240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
